Useful Materials

In this section, you can find resources to help patients, their family members and caregivers to learn more about lung cancer, bladder cancer, and immunotherapy.

Useful materials

Drug Assistance Item46

The main objective of The Comunity Care Fund (CCF) is to provide assistance to people facing financial difficulties. Immunotherapy has been included in the subsidy coverage of the CCF Medical Assistance Programme since May 2020, for treating patients with stage III NSCLC. To be eligible for financial assistance, the patient must be an HA patient and fulfill all of the following requirements.

Clinical Requirement

Identity Requirement

The patient must be an "Eligible Person" within the meaning of the latest relevant government gazette published under the Hospital Authority Ordinance (Cap. 113).

Financial Condition Requirement

Applicants must pass a "household-based" financial assessment conducted by Medical Social Worker (MSW).46

* Research has shown that stage III NSCLC patients with PD-L1 expression level less than 1% can still receive immunotherapy. Patients with stage III NSCLC who fulfill medical requirements can receive immunotherapy as self-financed item, for a maximum period of 12 months.47

Other than that, "SafeMed Dispensary" of the Hong Kong Pharmaceutical Care Foundation provides "Stage 3 Lung Cancer Concurrent Chemoradiation Subsidy Program" for eligible stage III non-small cell lung cancer patients at any private hospitals or private oncology centers in Hong Kong. Click here to download the "Stage 3 Lung Cancer Concurrent Chemoradiation Subsidy Program" leaflet or call 2979 0380 for more details.